Intercept Pharmaceuticals Correlations

ICPT
 Stock
  

USD 13.95  2.46  14.99%   

The correlation of Intercept Pharmaceuticals is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intercept Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intercept Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Please see Risk vs Return Analysis.
  
The ability to find closely correlated positions to Intercept Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intercept Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intercept Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intercept Pharmaceuticals to buy it.

Moving together with Intercept Pharmaceuticals

+0.61GBTGGlobal Business TravelPairCorr
+0.62WMTWalmartPairCorr

Moving against Intercept Pharmaceuticals

-0.64OSTKOOVERSTOCK COM INCPairCorr

Related Correlations

ADTTF
IFNNY
ASMIY
MCHP
LRCX
ASML
STMEF
ADTTF
0.830.810.770.840.820.72
ADTTF
IFNNY
0.830.910.860.960.960.88
IFNNY
ASMIY
0.810.910.920.880.910.94
ASMIY
MCHP
0.770.860.920.830.840.93
MCHP
LRCX
0.840.960.880.830.980.82
LRCX
ASML
0.820.960.910.840.980.83
ASML
STMEF
0.720.880.940.930.820.83
STMEF
ADTTF
IFNNY
ASMIY
MCHP
LRCX
ASML
STMEF
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ASMLLRCX
LRCXIFNNY
ASMLIFNNY
STMEFASMIY
STMEFMCHP
MCHPASMIY
  

Intercept Pharmaceuticals Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Intercept Stock performing well and Intercept Pharmaceuticals company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Intercept Pharmaceuticals' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Intercept Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

Intercept Pharmaceuticals Corporate Directors

Intercept Pharmaceuticals corporate directors refer to members of an Intercept Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Intercept Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Intercept Pharmaceuticals' board members must vote for the resolution. The Intercept Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Daniel Welch - DirectorProfile
Luca Benatti - Independent DirectorProfile
Klaus Veitinger - Independent DirectorProfile
Nancy MillerRich - DirectorProfile

Invested in Intercept Pharmaceuticals?

The danger of trading Intercept Pharmaceuticals is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Intercept Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Intercept Pharmaceuticals. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Intercept Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Risk vs Return Analysis. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for analysis

When running Intercept Pharmaceuticals price analysis, check to measure Intercept Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intercept Pharmaceuticals is operating at the current time. Most of Intercept Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Intercept Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intercept Pharmaceuticals' price. Additionally, you may evaluate how the addition of Intercept Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Intercept Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intercept Pharmaceuticals. If investors know Intercept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intercept Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Intercept Pharmaceuticals is measured differently than its book value, which is the value of Intercept that is recorded on the company's balance sheet. Investors also form their own opinion of Intercept Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Intercept Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intercept Pharmaceuticals' market value can be influenced by many factors that don't directly affect Intercept Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intercept Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Intercept Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intercept Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.